Citation Impact

Citing Papers

Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
2014
Prognostic impact and targeting of CRM1 in acute myeloid leukemia
2013
Acute Myeloid Leukemia
2015 Standout
KPT‐330 inhibitor of CRM1 (XPO1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of T‐cell acute lymphoblastic leukaemia and acute myeloid leukaemia
2013
MicroRNAs in Development and Disease
2011
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout

Works of Yueming Zhao being referenced

EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
2009
The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer
2012
Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
2009
Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1
2009
Rankless by CCL
2026